Resistance to at least 1 antimicrobial in 3 or more antimicrobial categories, which included extended-spectrum cephalosporins, fluoroquinolones, aminoglycosides, meropenem (all organisms); and piperacillin/tazobactam (Enterobacteriaceae and Pseudomonas aeruginosa). Denominators represent number of isolates tested to all antimicrobials/classes.
Central Retinal Artery Occlusion (CRAO) is the partial or complete blockage of the central retinal artery presenting as acute painless monocular vision loss with increased risk in those with cardiovascular disease. Diagnosis of CRAO requires a dilated fundoscopic exam performed by an Ophthalmologist. In resource limited hospitals, access to these expertise and resources may be difficult. Early recognition of CRAO in the emergency department (ED) can lead to reduced negative consequences and reduced cost to healthcare. Here we present a case using Point-of-Care Ultrasound (POCUS) to identify CRAO in a patient.
Angiotensin-converting enzyme inhibitors (ACE-I) are medications within the antihypertensive class that are used by nearly 108 million patients worldwide [1]. A rare but possibly life-threatening adverse effect of ACE-I is angioedema, which occurs due to elevated levels of bradykinin [2]. In this case report, we discuss a patient case where the use of tranexamic acid (TXA), an antifibrinolytic agent, prevented impending intubation due to ACE-I induced angioedema.
CaSe RepoRtCheck for updates was admitted to the intensive care unit with an O 2 saturation of 98% and observed for 24 hours without any interventions (Figure 2). Counseling was provided and ACE-I allergy was documented on electronic medical records prior to discharge.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.